Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022.
Saved in:
| Title: | Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022. |
|---|---|
| Authors: | DeSilva MB; HealthPartners Institute, Minneapolis, Minnesota, USA., Mitchell PK; Westat, Rockville, Maryland, USA., Klein NP; Kaiser Permanente Northern California Division of Research, Kaiser Permanente Vaccine Study Center, Oakland, California, USA., Dixon BE; Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana, USA.; Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana, USA., Tenforde MW; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Thompson MG; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Naleway AL; Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA., Grannis SJ; Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana, USA.; School of Medicine, Indiana University, Indianapolis, Indiana, USA., Ong TC; School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Natarajan K; Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, New York, USA.; New York Presbyterian Hospital, New York, New York, USA., Reese SE; Westat, Rockville, Maryland, USA., Zerbo O; Kaiser Permanente Northern California Division of Research, Kaiser Permanente Vaccine Study Center, Oakland, California, USA., Kharbanda AB; Children's Minnesota, Minneapolis, Minnesota, USA., Patel P; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Stenehjem E; Division of Infectious Diseases and Clinical Epidemiology, Intermountain Healthcare, Salt Lake City, Utah, USA., Raiyani C; Baylor Scott and White Health, Temple, Texas, USA., Irving SA; Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA., Fadel WF; Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana, USA.; Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana, USA., Rao S; School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Han J; Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, New York, USA., Reynolds S; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Davis JM; Westat, Rockville, Maryland, USA., Lewis N; Kaiser Permanente Northern California Division of Research, Kaiser Permanente Vaccine Study Center, Oakland, California, USA., McEvoy C; HealthPartners Institute, Minneapolis, Minnesota, USA., Dickerson M; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Dascomb K; Division of Infectious Diseases and Clinical Epidemiology, Intermountain Healthcare, Salt Lake City, Utah, USA., Valvi NR; Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana, USA., Barron MA; School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Goddard K; Kaiser Permanente Northern California Division of Research, Kaiser Permanente Vaccine Study Center, Oakland, California, USA., Vazquez-Benitez G; HealthPartners Institute, Minneapolis, Minnesota, USA., Grisel N; Division of Infectious Diseases and Clinical Epidemiology, Intermountain Healthcare, Salt Lake City, Utah, USA., Mamawala M; Baylor Scott and White Health, Temple, Texas, USA., Embi PJ; Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana, USA.; Vanderbilt University Medical Center, Nashville, Tennessee, USA., Fireman B; Kaiser Permanente Northern California Division of Research, Kaiser Permanente Vaccine Study Center, Oakland, California, USA., Essien IJ; HealthPartners Institute, Minneapolis, Minnesota, USA., Griggs EP; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Arndorfer J; Division of Infectious Diseases and Clinical Epidemiology, Intermountain Healthcare, Salt Lake City, Utah, USA., Gaglani M; Baylor Scott and White Health, Temple, Texas, USA.; Texas A&M University College of Medicine, Temple, Texas, USA. |
| Source: | The Journal of infectious diseases [J Infect Dis] 2023 Apr 18; Vol. 227 (8), pp. 961-969. |
| Publication Type: | Journal Article; Research Support, U.S. Gov't, P.H.S. |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36415904 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22DeSilva+MB%22">DeSilva MB</searchLink>; HealthPartners Institute, Minneapolis, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Mitchell+PK%22">Mitchell PK</searchLink>; Westat, Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Klein+NP%22">Klein NP</searchLink>; Kaiser Permanente Northern California Division of Research, Kaiser Permanente Vaccine Study Center, Oakland, California, USA.<br /><searchLink fieldCode="AU" term="%22Dixon+BE%22">Dixon BE</searchLink>; Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana, USA.; Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana, USA.<br /><searchLink fieldCode="AU" term="%22Tenforde+MW%22">Tenforde MW</searchLink>; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Thompson+MG%22">Thompson MG</searchLink>; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Naleway+AL%22">Naleway AL</searchLink>; Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Grannis+SJ%22">Grannis SJ</searchLink>; Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana, USA.; School of Medicine, Indiana University, Indianapolis, Indiana, USA.<br /><searchLink fieldCode="AU" term="%22Ong+TC%22">Ong TC</searchLink>; School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.<br /><searchLink fieldCode="AU" term="%22Natarajan+K%22">Natarajan K</searchLink>; Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, New York, USA.; New York Presbyterian Hospital, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Reese+SE%22">Reese SE</searchLink>; Westat, Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Zerbo+O%22">Zerbo O</searchLink>; Kaiser Permanente Northern California Division of Research, Kaiser Permanente Vaccine Study Center, Oakland, California, USA.<br /><searchLink fieldCode="AU" term="%22Kharbanda+AB%22">Kharbanda AB</searchLink>; Children's Minnesota, Minneapolis, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Patel+P%22">Patel P</searchLink>; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Stenehjem+E%22">Stenehjem E</searchLink>; Division of Infectious Diseases and Clinical Epidemiology, Intermountain Healthcare, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Raiyani+C%22">Raiyani C</searchLink>; Baylor Scott and White Health, Temple, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Irving+SA%22">Irving SA</searchLink>; Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Fadel+WF%22">Fadel WF</searchLink>; Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana, USA.; Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana, USA.<br /><searchLink fieldCode="AU" term="%22Rao+S%22">Rao S</searchLink>; School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.<br /><searchLink fieldCode="AU" term="%22Han+J%22">Han J</searchLink>; Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Reynolds+S%22">Reynolds S</searchLink>; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Davis+JM%22">Davis JM</searchLink>; Westat, Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Lewis+N%22">Lewis N</searchLink>; Kaiser Permanente Northern California Division of Research, Kaiser Permanente Vaccine Study Center, Oakland, California, USA.<br /><searchLink fieldCode="AU" term="%22McEvoy+C%22">McEvoy C</searchLink>; HealthPartners Institute, Minneapolis, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Dickerson+M%22">Dickerson M</searchLink>; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Dascomb+K%22">Dascomb K</searchLink>; Division of Infectious Diseases and Clinical Epidemiology, Intermountain Healthcare, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Valvi+NR%22">Valvi NR</searchLink>; Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana, USA.<br /><searchLink fieldCode="AU" term="%22Barron+MA%22">Barron MA</searchLink>; School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.<br /><searchLink fieldCode="AU" term="%22Goddard+K%22">Goddard K</searchLink>; Kaiser Permanente Northern California Division of Research, Kaiser Permanente Vaccine Study Center, Oakland, California, USA.<br /><searchLink fieldCode="AU" term="%22Vazquez-Benitez+G%22">Vazquez-Benitez G</searchLink>; HealthPartners Institute, Minneapolis, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Grisel+N%22">Grisel N</searchLink>; Division of Infectious Diseases and Clinical Epidemiology, Intermountain Healthcare, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Mamawala+M%22">Mamawala M</searchLink>; Baylor Scott and White Health, Temple, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Embi+PJ%22">Embi PJ</searchLink>; Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana, USA.; Vanderbilt University Medical Center, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Fireman+B%22">Fireman B</searchLink>; Kaiser Permanente Northern California Division of Research, Kaiser Permanente Vaccine Study Center, Oakland, California, USA.<br /><searchLink fieldCode="AU" term="%22Essien+IJ%22">Essien IJ</searchLink>; HealthPartners Institute, Minneapolis, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Griggs+EP%22">Griggs EP</searchLink>; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Arndorfer+J%22">Arndorfer J</searchLink>; Division of Infectious Diseases and Clinical Epidemiology, Intermountain Healthcare, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Gaglani+M%22">Gaglani M</searchLink>; Baylor Scott and White Health, Temple, Texas, USA.; Texas A&M University College of Medicine, Temple, Texas, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220413675%22">The Journal of infectious diseases</searchLink> [J Infect Dis] 2023 Apr 18; Vol. 227 (8), pp. 961-969. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, U.S. Gov't, P.H.S. – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0413675 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6613 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200221899%22">00221899 </searchLink><i>NLM ISO Abbreviation: </i>J Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36415904 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/infdis/jiac458 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 961 Titles: – TitleFull: Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: DeSilva MB – PersonEntity: Name: NameFull: Mitchell PK – PersonEntity: Name: NameFull: Klein NP – PersonEntity: Name: NameFull: Dixon BE – PersonEntity: Name: NameFull: Tenforde MW – PersonEntity: Name: NameFull: Thompson MG – PersonEntity: Name: NameFull: Naleway AL – PersonEntity: Name: NameFull: Grannis SJ – PersonEntity: Name: NameFull: Ong TC – PersonEntity: Name: NameFull: Natarajan K – PersonEntity: Name: NameFull: Reese SE – PersonEntity: Name: NameFull: Zerbo O – PersonEntity: Name: NameFull: Kharbanda AB – PersonEntity: Name: NameFull: Patel P – PersonEntity: Name: NameFull: Stenehjem E – PersonEntity: Name: NameFull: Raiyani C – PersonEntity: Name: NameFull: Irving SA – PersonEntity: Name: NameFull: Fadel WF – PersonEntity: Name: NameFull: Rao S – PersonEntity: Name: NameFull: Han J – PersonEntity: Name: NameFull: Reynolds S – PersonEntity: Name: NameFull: Davis JM – PersonEntity: Name: NameFull: Lewis N – PersonEntity: Name: NameFull: McEvoy C – PersonEntity: Name: NameFull: Dickerson M – PersonEntity: Name: NameFull: Dascomb K – PersonEntity: Name: NameFull: Valvi NR – PersonEntity: Name: NameFull: Barron MA – PersonEntity: Name: NameFull: Goddard K – PersonEntity: Name: NameFull: Vazquez-Benitez G – PersonEntity: Name: NameFull: Grisel N – PersonEntity: Name: NameFull: Mamawala M – PersonEntity: Name: NameFull: Embi PJ – PersonEntity: Name: NameFull: Fireman B – PersonEntity: Name: NameFull: Essien IJ – PersonEntity: Name: NameFull: Griggs EP – PersonEntity: Name: NameFull: Arndorfer J – PersonEntity: Name: NameFull: Gaglani M IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 04 Text: 2023 Apr 18 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1537-6613 Numbering: – Type: volume Value: 227 – Type: issue Value: 8 Titles: – TitleFull: The Journal of infectious diseases Type: main |
| ResultId | 1 |